The January Gauntlet: Five Economic Events That Could Define 2026's Direction
From the delayed jobs report to the Fed's first meeting and Powell's succession battle, January 2026 is packed with market-moving events. Here's your calendar.
TRENDING TOPICS
1366 articles found for "investing"
From the delayed jobs report to the Fed's first meeting and Powell's succession battle, January 2026 is packed with market-moving events. Here's your calendar.
Moody's chief economist Mark Zandi predicts three Fed rate cuts before midyear 2026—a more aggressive forecast than Wall Street or the Fed itself. Here's his reasoning.
Fortinet surged 69% and Cloudflare gained 59% as AI-powered threats drove record demand for security solutions, with the global market projected to hit $563 billion by 2032.
German defense giant Rheinmetall surged 164% in 2025 as NATO allies pledged to boost military spending to 5% of GDP, reshaping the European investment landscape.
Cryptocurrency theft hit $3.4 billion in 2025, with North Korean hackers stealing at least $2 billion. Here's what went wrong and how to protect your assets.
Trump Media and Technology Group announces plans to issue a new cryptocurrency token to shareholders, marking a major pivot into digital assets following its ETF launch.
2025 marked a historic turning point for cryptocurrency regulation. The GENIUS Act passed, SEC launched Project Crypto, and the turf war between regulators officially ended.
Brent crude falls 19% in 2025, marking its third consecutive year of losses. IEA projects a 4 million bpd surplus in 2026 as OPEC+ and geopolitics reshape energy markets.
Chipotle shares plunged 49% in 2025 as younger consumers buckled under student debt, stagnant wages, and inflation. The fast-casual chain's struggles reveal deeper consumer stress.
With an 83% probability the Fed stands pat in January, attention turns to who will succeed Jerome Powell when his term expires in May 2026.
Ford takes a $19.5 billion hit, GM writes down $1.6 billion, and Stellantis invests $13 billion in gas vehicles as America's automakers abandon their all-electric dreams.
Axsome Therapeutics stock jumps to 52-week high after FDA accepts and grants priority review for AXS-05 to treat Alzheimer's disease agitation, with decision expected by April 2026.